El Salvador vs Peru: Access to anti-retroviral drugs, male
El Salvador
78.0%
in 2024
Peru
79.0%
in 2024
El Salvador rank
51st
Peru rank
49th
Access to anti-retroviral drugs, male over time
- El Salvador
- Peru
How they compare
Peru currently reports 79.0% against 78.0% in El Salvador, a difference of 1.0%.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was Peru ahead.
El Salvador ranks 51st and Peru ranks 49th of 141 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.1% | 6.2% | 6.9% | El Salvador |
| 2010s | 50.7% | 43.1% | 7.6% | El Salvador |
| 2020s | 75.4% | 74.4% | 1.0% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, El Salvador or Peru?
- Peru, at 79.0% against 78.0% in El Salvador as of 2024.
- What is the difference in access to anti-retroviral drugs, male between El Salvador and Peru?
- 1.0%, with Peru ahead.
- How many years of comparable data are there for El Salvador and Peru?
- 25 years are reported by both, from 2000 to 2024.
- How do El Salvador and Peru rank globally for access to anti-retroviral drugs, male?
- El Salvador ranks 51st and Peru ranks 49th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.